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The activation of inflammasomes containing NBD-LRR (NLRs) or non-NLRs is critical for effective host
defense against microbial pathogens. Recent discoveries have uncovered a plethora of pathogenic strate-
gies to inhibit inflammasome-mediated processing of IL-1b and IL-18. We review recent evidence for viral
and bacterial manipulation of the inflammasome, ranging from perturbation of caspase-1 activation to target-
ing of specific inflammasome components.Role of the Inflammasome in Combating Pathogenic
Infection
The innate immune response stands at the forefront of detecting
‘‘danger’’ signals, whether foreign or intrinsic. Germline-
encoded pattern recognition receptors (PRRs) mediate the
detection of viral and bacterial cell components. These PRRs
include toll-like receptors (TLRs), RIG-I-like receptors (RLRs),
and nucleotide-binding domain and leucine-rich repeat proteins
(NLRs). Pathogens activate the transcriptional and translational
induction of a range of proinflammatory cytokines but also elicit
the activation of a multimeric protein complex known as the
inflammasome, which is critical in the proteolytic processing of
pro-IL-1b and pro-IL18 into their mature active forms. The in-
flammasome is classically composed of an NLR, the adaptor
molecule PYCARD/ASC, and procaspase-1, which, when pro-
teolyzed to caspase-1, provides the enzymatic activity of the
inflammasome. Procaspase-1 forms the core of the inflamma-
some; however, the constitution of NLRs within the inflamma-
some varies according to the pathogen involved. NLRP3 (cryo-
pyrin, NALP3) represents the NLR most widely used by viral
and bacterial pathogens, whereas NLRP1 and NLRC4 inflamma-
somes respond to a subset of bacterial pathogens. Non-NLR
inflammasomes containing the HIN2 protein AIM2 and the viral
sensor RIG-I have also been described (Pedra et al., 2009; Poeck
et al., 2010; Hornung and Latz, 2010).
IL-1b is critical in the host defense against a number of
bacteria and viruses, and pathogens have evolved mechanisms
to prolong their survival by inhibiting IL-1b transcription and by
producing IL-1b decoy receptors (Dinarello, 2009). Recent
studies have revealed an increasing number of pathogenic viru-
lence factors that function to target the inflammasome and
inhibit IL-1b processing. Examples of the mechanisms by which
viruses and bacteria repress inflammasome activation to inhibit
IL-1b secretion are outlined within the context of the two-step
activation of IL-1b (Figure 1). In addition, specific information
about the genes involved is provided in the sections below and
summarized in Table 1. Because host inhibition of the inflamma-
some has many parallels to pathogen-mediated inhibition of the
inflammasome, the former will be briefly discussed.Host-Derived Inhibition of the Inflammasome
Host suppression of the inflammasome is essential because
prolonged inflammatory response beyond eradication of a
foreign or self-insult can lead to excessive tissue damage. Path-
ways of deactivation are important to understand because they
provide potential targets or mimics for pathogens in their
attempts to achieve immune stealth by minimizing the inflam-
matory response. Because PYCARD is an adaptor molecule
shared by a variety of NLR and non-NLR inflammasome
complexes, a PYCARD-binding molecule provides an attractive
target for deactivation of the inflammasome. One well-charac-
terized family of inhibitors of PYCARD is the cellular PYRIN
domain (PYD)-only proteins (POP) family. Mammalian cPOP1
and cPOP2 disrupt inflammasome activation by binding
PYCARD and blocking its interaction with NLRs (Stehlik et al.,
2003; Dorfleutner et al., 2007; Bedoya et al., 2007). The serpin
proteinase inhibitor 9 (PI-9), on the other hand, directly inhibits
caspase-1 activity through protein-protein interaction (Young
et al., 2000). PI-9 is expressed by vascular smooth muscle cells
and a variety of normal tissues, and its expression correlates
inversely with that of IL-1b. Caspase-12 also can directly asso-
ciate with caspase-1 to inhibit its activity. Polymorphisms in the
human caspase-12 gene confer increased sepsis (Saleh et al.,
2004), and its deficiency in mice impedes bacterial clearance
(Saleh et al., 2006). An additional class of host inflammasome
inhibitors is represented by the Bcl family of cell survival
proteins. Bcl-2 and Bcl-XL can directly bind to NLRP1 to disrupt
the activation of its inflammasome and subsequent IL-1b pro-
cessing (Bruey et al., 2007). Another seminal study shows that
T cells, in addition to profoundly regulating the adaptive immune
response, are key regulators of innate immunity via the specific
inhibition of inflammasomes. CD4+ T cells inhibit the activa-
tion of NLRP3 and NLRP1 inflammasomes, but not the NLRC4
inflammasome (Guarda et al., 2009). This suppression can be
replicated by TNF family ligands such as CD40L. Collectively,
these studies have expanded our understanding of host mech-
anisms for suppressing inflammasome activation and have
provided rationales for pathways that pathogens have evolved
to target.Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 7
Figure 1. Suppression of the Two-Step
Regulation of IL-1b Production by Viruses
and Bacteria
Host IL-1b release is prompted by a two-step
process. First, the activation of NF-kB and AP-1
leads to the transcription of pro-IL-1b. A second
signal sensed by an NLR triggers the assembly
of the inflammasome and the subsequent activa-
tion of caspase-1. Active caspase-1 proteolyti-
cally processes pro-IL-1b into IL-1b for release.
Viruses and bacteria have developed an array of
strategies to interfere with inflammasome activa-
tion. Myxoma and Shope fibroma viruses utilize
POP-like proteins M013 and gp013L to bind ASC/
PYCARD and prevent inflammasome assembly.
Poxviruses also express the serpins crmA, B13R,
Serp2, and SPI-2, which disrupt the proteolytic
activity of caspase-1, potentially through direct
binding to caspase-1. Influenza A virus and
baculovirus express NS1 and p35, and Y. entero-
colitica expresses Yop E and YopT that disrupt
caspase-1 oligomerization. The P. aeruginosa
effector molecules ExoU and ExoS block the acti-
vation of the NLRC4 inflammasome, and the
Mycobacterium tuberculosis gene zmp1 may
target the NLRP3 inflammasome. Pneumolysin
of Streptococcus pneumonia also blocks IL-1b
release by diminishing caspase-1 activity. YopK
of Yersinia pseudotuberculosis has a unique
mechanism in that it binds to T3SS and masks
detection by the inflammasome. Though each of these proteins inhibits caspase-1 activation, it is not known in most cases whether caspase-1 is directly
targeted or whether effects are mediated indirectly by targeting of an upstream regulator.
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Poxviruses Produce cPOP and Serpin Homologs that
Bind and Target PYCARD and Caspase-1
In a 2005 study, a PYD containing protein analogous to the host-
derived cPOP proteins was identified from myxoma virus,
a member of the poxvirus family (Johnston et al., 2005). This
myxoma virusM013 protein is essential for productive viral infec-
tion and, like cPOP1 and cPOP2, binds PYCARD to prevent in-
flammasome activation. The poxvirus Shope fibroma virus
encodes an additional cPOP homolog, gp013L, which, like
M013, colocalizes with PYCARD when transfected into cells
and can also reduce NLRP3-mediated IL-1b processing in a re-
constituted cell system (Dorfleutner et al., 2007). Both M013 and
gp013L were shown to possess an additional inhibitory activity
on the transcription of IL-1b and other proinflammatory cyto-
kines through repression of NF-kB (Dorfleutner et al., 2007; Rah-
man et al., 2009). These combined studies demonstrate that the
poxvirus vPOPs simultaneously target inflammasome activation
and NF-kB activation to provide dual regulation of IL-1b at the
level of transcription and processing.
An additional strategy of poxviruses involves the production of
viral serpins analogous to the mammalian PI-9 protein (Young
et al., 2000). In a landmark study, the cowpox gene crmA was
identified as a potent host immune suppressor and a specific
inhibitor of caspase-1 (Ray et al., 1992). Extracts from cowpox-
infected cells can block the processing of IL-1b, and this property
is lost when crmA is inactivated. Furthermore, purified CrmA
protein abrogates the proteolytic activity of caspase-1. Vaccinia
virus expresses a gene B13R that is highly homologous to crmA
and is required for inhibition of IL-1b processing in vaccinia-in-
fected THP1 monocytic cells (Kettle et al., 1997). The myxoma
virus counterpart of CrmA andB13R, Serp2, immunoprecipitates
with caspase-1, suggesting that direct interaction may mediate8 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.the inhibitory function of the poxvirus serpins (Petit et al., 1996).
A similar caspase-1-inhibiting protein is encoded by ectromelia
virus, a murine orthopoxvirus (Turner et al., 2000). Thus, the
production of serpin PI-9 homologs appears to be an evolution-
arily preserved andadvantageous inhibitorymechanismadopted
by multiple viruses to subvert host immunity.
Additional Viral Proteins that Inhibit Inflammasome
Activity
A dsRNA virus and a member of the Orthomyxoviridae, influenza
A virus encodes 10 proteins, among which the nonstructural
protein NS1 is critical for evasion of host immune defense (Sta-
sakova et al., 2005). NS1 is a 26 KD protein that dimerizes to
prevent nuclear export of host mRNA, activation of protein
kinase (PKR), and the type I interferon response. Viruses ex-
pressing NS1 bearing mutations within the RNA-binding and
dimerization domains induce significantly elevated levels of cas-
pase-1 activation and IL-1b and IL-18 secretion in primary
human macrophages, suggesting that NS1 constitutes an addi-
tional viral protein that inhibits inflammasome activation.
Baculovirus expresses the antiapoptotic protein p35, which
also can inhibit caspase-1 (Bump et al., 1995). Coexpression of
p35 with caspase-1 in a cell line that constitutively expresses
pro-IL-1bdecreases the releaseof IL-1b. Furthermore,purified re-
combinant p35 can inhibit the enzymatic activity of caspase-1. To
date, this protein has no identifiable structural domains and no
knownhumanhomolog; thus, it couldpotentially compriseanovel
class of inflammasome inhibitors.
Bacterial Inhibition of the Inflammasome
Pseudomonas aeruginosa and Yersinia Species Utilize
the T3SS to Prevent Inflammasome Activation
The type III secretion system (T3SS) provides a mechanism for
inserting bacterial virulence factors into the host cell, and it is
Table 1. Examples of Viruses and Bacteria that Inhibit IL-1b Release as a Pathogenic Stealth Mechanism
Gene/Protein Pathogen Classification Function References
M013 Myxoma virus cPOP homolog binds PYCARD and inhibits
caspase-1 activation
Johnston et al., 2005
gp013L Shope fibroma virus cPOP homolog binds PYCARD and inhibits
inflammasome activation
Dorfleutner et al., 2007
crmA Cowpox virus serpin inhibits caspase-1 activation Ray et al., 1992
B13R Vaccinia virus serpin inhibits caspase-1 activation Kettle et al., 1997
Serp2 Myxoma virus serpin binds caspase-1 and inhibits
caspase-1 activation
Petit et al., 1996
SPI-2 Ectromelia virus serpin inhibits caspase-1 activity Turner et al., 2000
NS1 Influenza A virus ds RNA-binding protein inhibits caspase-1 activation Stasakova et al., 2005
p35 Baculovirus unknown inhibits caspase-1 activation Bump et al., 1995
ExoU Pseudomonas aeruginosa
PA103
exoenzyme inhibits IL-1b, caspase-1
activation within the NLRC4
inflammasome
Sutterwala et al., 2007




Galle et al., 2008
YopE Yersinia enterocolitica GTPase-activating protein inhibits IL-1b, caspase-1
activation/oligomerization
Schotte et al., 2004
YopT Yersinia enterocolitica cysteine protease inhibits IL-1b, caspase-1
activation/oligomerization
Schotte et al., 2004
YopK Yersinia pseudotuberculosis T3SS-binding protein prevents inflammasomal
recognition of the T3SS
Brodsky et al., 2010
zmp1 Mycobacterium
tuberculosis/BCG
Zn2+ metalloproteinase inhibits IL-1b, caspase-1
activation by NLRP3
inducers
Master et al., 2008
pneumolysin Streptococcus pneumoniae pore-forming toxin inhibits IL-1b, caspase-1
activation
Littmann et al., 2009
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minimize the inflammasome response. Pseudomonas aerugi-
nosa induces NLRC4-dependent IL-1b release; however, one
strain of P. aeruginosa, PA103, fails to induce caspase-1 activa-
tion and IL-1b release (Sutterwala et al., 2007). This effect was
shown to be mediated by the T3SS effector molecule Exoen-
zyme U (ExoU). The ability of ExoU to suppress caspase-1 is
attributed to its phospholipase activity, though it is not clear
how this activity relates mechanistically to its inhibitory function.
ExoS also negatively regulates caspase-1-mediated IL-1b pro-
cessing (Galle et al., 2008). Of interest, ExoS is a bifunctional
protein with an N-terminal Rho GTPase domain and a C-terminal
ADP-ribosyltransferase domain.
Yersinia also produces a set of T3SS effector molecules, the
Yops, which can modulate inflammasome response. Y. entero-
colitica deficient in YopE and YopT induces elevated caspase-
1 maturation and IL-1b secretion in a murine macrophage cell
line (Schotte et al., 2004). Furthermore, YopE and YopT were
found to modulate the oligomerization of caspase-1. Like ExoS
of P. aeruginosa, YopE serves as a Rho GTPase-activating
protein, whereas YopT is a cysteine protease. Though the rele-
vance of these activities to caspase-1 inhibition is unclear, this
suggests a commonality in function of the T3SS effector mole-
cules in blocking inflammasome activation.
A recent study shows that YopK of Y. pseudotuberculosis has
an entirely unique mechanism for interfering with inflammasome
activation (Brodsky et al., 2010). The T3SS of Y. pseudotubercu-losis activates NLRP3- and NLRC4-dependent caspase-1 pro-
cessing, but YopK associates with the T3SS translocon to
mask its detection by the inflammasome. This is significant
because it represents the first study in which an effector mole-
cule binds to the T3SS to avoid host detection. It is likely that
analogous proteins may exist for other T3SS bacteria.
Mycobacterium tuberculosis Produces a Zn2+
Metalloprotease that Inhibits Inflammasome Activation
by NLRP3 Inflammasome Inducers
IL-1b is not highly activated during infection with Mycobacte-
rium tuberculosis (Mtb) or related species such as the vaccine
strain Mycobacterium bovis (referred to below as BCG). The
zmp1 gene from BCG encodes a Zn2+ metalloprotease that is
required for mycobacterial suppression of IL-1b processing
(Master et al., 2008). BCG infection also prevents activation
of caspase-1 triggered by the simultaneous administration of
NLRP3 inflammasome agonists nigericin and ATP. This is
a significant finding because it suggests that BCG orchestrates
an active process to repress inflammasome activation induced
by an independent infection-induced second signal. Of interest,
caspase-1/ mice infected with Mtb exhibit WT levels of both
pro-IL-1b and processed IL-1b. Despite the persistence of
IL-1b, these mice display elevated lung burdens and decreased
survival compared to WT mice (Mayer-Barber et al., 2010). This
suggests that caspase-1 plays other protective roles in Mtb
infection besides IL-1b processing, such as regulating cell
death.Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 9
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Toxin that Suppresses the Inflammasome
Streptococcus pneumoniae utilizes a number of virulence factors
for successful colonization. Among these, the cholesterol-depen-
dent pore-forming exotoxin, pneumolysin, is implicated in
S. pneumoniae-induced host tissue damage. Pneumolysin-defi-
cient bacteria induce elevated caspase-1 activation and IL-1b
secretion in human DCs (Littmann et al., 2009). This is surprising
because other pore-forming toxins, by contrast, are known to acti-
vate caspase-1 (Cordoba-Rodriguez et al., 2004; Craven et al.,
2009).Pneumolysin-deficientS.pneumoniaealsoexhibitselevated
levels of immature IL-1b, suggesting that pneumolysin modifies
host cell signaling pathways such as NF-kB or MAP kinase to
simultaneously suppress the expression and processing of IL-1b.Concluding Remarks
Throughoutevolution, pathogenshavedevelopedmechanisms to
circumvent host immune detection via a wide range of strategies.
Because IL-1b is critical in the effort to eradicate foreignmicrobial
infection, inflammasome-mediated signaling pathways provide
an obvious target for achieving pathogenic stealth by minimizing
the host immune response. Though IL-1b inhibition appears to
be the primary target of pathogen-mediated inflammasome inhi-
bition, studieswithMtbdemonstrate that inflammatoryprocesses
in addition to IL-1b processing, such as pathogen-mediated cell
death, may be targeted for the benefit of the pathogen. Viruses
and bacteria inhibit multiple stages of inflammasome activation.
Poxviruses produce cPOP homologs that directly bind PYCARD
and thereby prevent inflammasome assembly. In addition, abun-
dant evidence points to caspase-1 as a prime target for suppres-
sion of IL-1b production; however, in many cases, it is not known
whether caspase-1 is directly targeted or whether an unknown
upstream mediator is involved. NLRP1 is a target for host Bcl
family proteins (Bruey et al., 2007); however, as yet, no path-
ogen-derived IL-1b inhibitors have been shown to function
through direct interaction with an NLR component of the inflam-
masome. It is intriguing that several pathogen-encoded proteins
showspecificity for particularNLR inflammasomepathways, sug-
gesting that such regulators may exist. The pathogen-derived in-
flammasome inhibitors identified thus far range from serpins to
enzymes topore-forming toxins, suggesting that themechanisms
that haveevolved toperturb the inflammasomearewidespread. In
each of the examples presented, inflammasome inhibition is
beneficial to the pathogen; however, it is possible that, in cases
of excessive inflammasome activation leading to tissue destruc-
tion, inhibition might be beneficial to the host. Future challenges
include the elucidation of mechanisms connecting pathogen-
derived ligands to caspase-1 activation. For example, in most
cases, it has not been determined whether pathogenic proteins
affect inflammasome assembly, the function of the mature cas-
pase-1 protein, or an upstream mediator of the inflammasome.
Elucidation of these mechanisms will lead to the development of
novel approaches toward controlling infectious diseases and
other inflammasome-dependent inflammatory processes.ACKNOWLEDGMENTS
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